Clinical significance of CA125 in unresectable pancreatic cancer treated with first-line chemotherapy.

Authors

null

Iori Motoo

Third Department of Internal Medicine, University of Toyama, Toyama, Japan;

Iori Motoo , Takayuki Ando , Satoshi Yuki , Ken Ito , Akira Ueda , Yosuke Kito , Miho Sakumura , Shinya Kajiura , Jun Matsuno , Yoshifumi Nakamura , Yuma Inoue , Nobuhiko Hayashi , Ayumu Hosokawa , Kazuto Shibuya , Haruyoshi Tanaka , Mina Fukasawa , Tsutomu Fujii , Ichiro Yasuda

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Track

Pancreatic Cancer,Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Small Bowel Cancer

Sub Track

Tumor Biology, Biomarkers, and Pathology

Citation

J Clin Oncol 41, 2023 (suppl 4; abstr 745)

DOI

10.1200/JCO.2023.41.4_suppl.745

Abstract #

745

Poster Bd #

M12

Abstract Disclosures

Similar Posters

First Author: Hannah Marie Cherniawsky

Poster

2023 ASCO Gastrointestinal Cancers Symposium

Efficacy of the third-line chemotherapy in patients with advanced pancreatic cancer.

Efficacy of the third-line chemotherapy in patients with advanced pancreatic cancer.

First Author: Bomi Kim

Poster

2023 ASCO Gastrointestinal Cancers Symposium

Interim analysis results of gut microbiota in patients with unresectable cholangiopancreatic cancer: SCRUM-Japan MONSTAR-SCREEN.

Interim analysis results of gut microbiota in patients with unresectable cholangiopancreatic cancer: SCRUM-Japan MONSTAR-SCREEN.

First Author: Shun Tezuka